New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 17, 2012
12:34 EDTHZNPFarallon Capital reports 5.4% passive stake in Horizon Pharma
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:24 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
07:12 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $450M-$475M from $425M-$450M
Subscribe for More Information
07:10 EDTHZNPHorizon Pharma reports Q4 adjusted EPS 27c, consensus 22c
Reports Q4 revenue $103.8M, consensus $95.54M.
February 20, 2015
10:20 EDTHZNPHigh option volume stocks
Subscribe for More Information
07:08 EDTHZNPAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 13, 2015
08:11 EDTHZNPHorizon Pharma submits IND application for ACTIMMUNE
Horizon Pharma announced it has submitted an Investigational New Drug, or IND, application to the FDA for ACTIMMUNE in the treatment of Friedreich's Ataxia, or FA. The company has simultaneously requested Fast Track Designation. The company plans to begin a Phase 3 study in Q2 in collaboration with the Friedreich's Ataxia Research Alliance, or FARA, and the investigators and clinics of FARA's Collaborative Clinical Research Network, or CCRN, in FA.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use